Cargando…
Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation
Activation of programmed cell death 1 (PD-1)/PD-ligand 1 (PD-L1) can promote immune suppression of the tumor microenvironment. However, the effects and mechanisms of PD-L1 silencing on colorectal cancer growth are largely unknown. In the present study, PD-L1 expression was compared in colorectal can...
Autores principales: | Chen, Yilin, Huang, Ying, Lu, Xingrong, Wang, Gaoxiong, Chi, Pan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196599/ https://www.ncbi.nlm.nih.gov/pubmed/30272332 http://dx.doi.org/10.3892/or.2018.6738 |
Ejemplares similares
-
Immunoregulation of macrophages by dynamic ligand presentation via ligand–cation coordination
por: Kang, Heemin, et al.
Publicado: (2019) -
Immunoregulation and genotype in colorectal cancer
por: Church, Sarah E, et al.
Publicado: (2015) -
Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer
por: Chen, Yan, et al.
Publicado: (2021) -
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes
por: Coto-Llerena, Mairene, et al.
Publicado: (2020) -
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
por: Kamata, Toshiko, et al.
Publicado: (2016)